Buy out possibilities ....
With a buyout it will be based on the value of the intellectual property, 21 patents, new ip on the way, drugs already being sold, contracts, Orphan Drug Status-Pediatric MS, opioid alternative, GSA, any new R&D under way, 10 drug pipeline, and on and on folks.
I believe NPHC has many material events in the making. We will continue to see major developments underway over the next days/weeks ahead. Each event will grow value. So does a pharma buy out Nutra Pharma today? Time will tell.
Lets take a stab at valuing NPHC today, very conservatively.
Lets begin with the loss carry forwards worth 15-20 million in cash before we event start.
What that means is before you even begin to value the list of assets above you start at a penny.
**VERY CONSERVATIVE BUYOUT VALUE TODAY**
*** Orphan drug status and the opioid alternative can grow value daily as progress is made, contracts, build out, big Pharma's difficulties with the opioid crisis and FDA Trials.
Loss on the books carry forward .01 cent
Buyer gets this in their own pockets after sale is complete from tax savings! Essentially 20 million buyout price for free to the buyer!
Orphan Drug Status 40 million market cap today. .02 cents
Worth more IMHO value will increase when we reach FDA Phase II trials
Opioid Alternative 20 million market cap today .01 cent
In the GSA (Govt.) looking to help the Military/VA. This will increase as material events proceed. Bet on it.
10 drug pipeline 10 million market cap today .005 cent
Includes value for R&D and patents 10 drugs.
Each drug in the pipeline has value in research and development completed. Some are further in progress than others. For ten drugs .005 is very conservative.
Pet Pain Away .0025 cents
Very conservative buyout value today: .0475
I will reiterate this number will grow considerably as material events and advancement in the IP is made!!!
News 
Market Data 
Discover 
